Tractor Supply Company ( TSCO Quick Quote TSCO - Free Report) has delivered lower-than-expected results in fourth-quarter 2019. Results were hurt by soft comparable store sales performance in the reported quarter, owing to unfavorable weather that affected sales of seasonal products. Also, sluggishness in certain holiday discretionary categories impacted the company’s performance.
The dismal results might have hurt investors’ sentiments. Notably, shares of the Zacks Rank #3 (Hold) company have dipped 13% in the past six months compared with the
industry’s 6.7% decline. Q4 Highlights
Tractor Supply’s adjusted earnings were $1.21 per share, which lagged the Zacks Consensus Estimate of $1.23. However, the bottom line improved 9% from the prior-year quarter. Including the after-tax impact of the executive transition agreement, the company reported earnings of $1.02 per share.
Net sales grew 2.7% to $2,191.8 million but missed the Zacks Consensus Estimate of $2,243 million. The year-over-year improvement was driven by comps increase of 0.1%, led by growth of 1.8% in average ticket. Meanwhile, comparable store transaction count declined 1.7%.
Keeping in these lines, comparable store sales performance was backed by strength in the consumable, usable and edible categories. However, adverse weather and softness in certain holiday discretionary categories acted as deterrents.
Margins & Costs
Gross profit rose 3.6% year over year to $741.8 million, with gross margin expansion of 26 basis points (bps) to 33.8%. The uptick was driven by lower freight costs as a percent of sales and better management of direct product margins.
Selling, general and administrative (SG&A) expenses — including depreciation and amortization — as a percentage of sales grew 3 bps to 25.2%. Higher costs related to a new distribution facility in Frankfort, NY, along with rise in other costs related to occupancy and store personnel led to the upside. These expenses were somewhat offset by decreased incentive compensation and improved cost management.
Tractor Supply ended the quarter with cash and cash equivalents of $84.2 million, long-term debt of $366.5 million, and total stockholders’ equity of $1,567.1 million.
The company returned $696 million via share repurchases worth $533.3 million and dividends of $162.7 million in 2019. Additionally, it incurred capital expenditure of $217.5 million, while generated cash flow from operating activities of $811.7 million.
For 2020, management expects share buybacks of $450-$550 million compared with $525-$550 million mentioned earlier. Moreover, the company continues to expect capital expenditure of $225-$275 million.
In the quarter under review, Tractor Supply opened 30 namesake and one Petsense stores, while shuttered one Petsense outlet. As of Dec 28, 2019, the company operated 1,844 Tractor Supply stores across 49 states and 180 Petsense stores in 26 states.
For 2020, management expects to open 80 namesake stores and 10-15 Petsense stores.
Tractor Supply Company Price, Consensus and EPS Surprise
Outlook Additionally, management issued guidance for 2020. Tractor Supply now projects net sales of $8.75-$8.9 billion for the year, with comps growth of 1.5-3%. Operating margin is estimated to be 8.9%.
Moreover, the company envisions net income of $575-$595 million for 2020. Also, it expects earnings per share of $4.9-$5.1 for 2020, whereas it reported $4.68 in 2019.
Stocks to Consider
DICK’S Sporting Goods
DKS has an expected long-term earnings growth rate of 5.7%. It currently flaunts a Zacks Rank #1 (Strong Buy). You can see . the complete list of today’s Zacks #1 Rank stocks here
ZUMZ has an expected long-term earnings growth rate of 12%. It currently sports a Zacks Rank #1.
Boot Barn Holdings
BOOT has an impressive long-term earnings growth rate of 17% and a Zacks Rank #2 (Buy) at present. Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>